These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7887385)

  • 21. Effects of low-dose treatment with felodipine versus fosinopril in Chinese patients with nonischemic heart failure and normal blood pressure: A double-blind, randomized, crossover study.
    Lin MS; Chan KA; Wang CH; Chang NC
    Curr Ther Res Clin Exp; 2004 Mar; 65(2):204-21. PubMed ID: 24936117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of captopril and ibopamine in mild to moderate heart failure.
    Dohmen HJ; Dunselman PH; Poole-Wilson PA
    Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
    J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure.
    Lechat P; Garnham SP; Desche P; Bounhoure JP
    Am Heart J; 1993 Sep; 126(3 Pt 2):798-806. PubMed ID: 8166887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy.
    Leier CV; Binkley PF; Starling RC; Huss-Randolph P
    Am Heart J; 1989 May; 117(5):1092-8. PubMed ID: 2523634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study.
    Packer M; Narahara KA; Elkayam U; Sullivan JM; Pearle DL; Massie BM; Creager MA
    J Am Coll Cardiol; 1993 Jul; 22(1):65-72. PubMed ID: 8509565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years.
    Packer M; Pitt B; Rouleau JL; Swedberg K; DeMets DL; Fisher L
    JACC Heart Fail; 2017 Jun; 5(6):399-407. PubMed ID: 28501522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of congestive heart failure: experience with fosinopril.
    Blumenthal M
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):289S-298S. PubMed ID: 9366286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.
    Kubo SH; Gollub S; Bourge R; Rahko P; Cobb F; Jessup M; Brozena S; Brodsky M; Kirlin P; Shanes J
    Circulation; 1992 Mar; 85(3):942-9. PubMed ID: 1537130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
    Franciosa JA; Weber KT; Levine TB; Kinasewitz GT; Janicki JS; West J; Henis MM; Cohn JN
    Am Heart J; 1982 Sep; 104(3):587-94. PubMed ID: 7051796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure.
    Morisco C; Cuocolo A; Romano M; Nappi A; Iaccarino G; Volpe M; Salvatore M; Trimarco B
    Am J Cardiol; 1996 Mar; 77(7):480-5. PubMed ID: 8629588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure therapy with cilazapril: an overview.
    Dössegger L; Nielsen T; Preston C; Arabatzis N
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S38-41. PubMed ID: 7700063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group.
    Davies RF; Beanlands DS; Nadeau C; Phaneuf D; Morris A; Arnold JM; Parker JO; Baigrie R; Latour P; Klinke WP
    J Am Coll Cardiol; 1991 Dec; 18(7):1602-9. PubMed ID: 1960303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
    Gheorghiade M; Gattis WA; O'Connor CM; Adams KF; Elkayam U; Barbagelata A; Ghali JK; Benza RL; McGrew FA; Klapholz M; Ouyang J; Orlandi C;
    JAMA; 2004 Apr; 291(16):1963-71. PubMed ID: 15113814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure.
    Kholeif MA; Pringle S; Kesson E; Murray G; Kennedy JA; Lorimer AR; Stock JK; Brown JJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S180-3. PubMed ID: 1725036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.